TITLE

ZOOM CHROMOENDOSCOPY TO DETECT DYSPLASIA IN BARRETT'S OESOPHAGUS

AUTHOR(S)
Raman, V. S.; Krasner, N.; Ragunath, K.; Haqqani, M.
PUB. DATE
April 2004
SOURCE
Gut;Apr2004 Supplement 3, Vol. 53, pA58
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Dysplasia within Barrett's epithelium (BE) is the most practical marker for potential progression to cancer. Targeted biopsy using Zoom endoscopy may provide better yield for dysplasia. The study was conducted to examine the utility of methylene blue chromoendoscopy (MBC) with a high resolution zoom gastroscope to detect dysplasia in BE. MBC with a zoom gastroscope helps to target biopsies to high yield dysplastic areas within BE. If these preliminary results were validated, it would potentially eliminate the need for random biopsies.
ACCESSION #
13219040

 

Related Articles

  • A 115-bp MethyLight assay for detection of p16 (CDKN2A) methylation as a diagnostic biomarker in human tissues. Jing Zhou; Jie Cao; Zheming Lu; Hongwei Liu; Dajun Deng // BMC Medical Genetics;2011, Vol. 12 Issue 1, p67 

    Background: p16 Methylation is a potential biomarker for prediction of malignant transformation of epithelial dysplasia. A probe-based, quantitative, methylation-specific PCR (MSP) called MethyLight may become an eligible method for detecting this marker clinically. We studied oral mucosa...

  • AKT answer relating to tumour markers.  // InnovAiT;Nov2009, Vol. 2 Issue 11, p693 

    The answer to an applied knowledge test on tumour markers is presented.

  • AKT question relating to tumour markers. Nandakumar, Michael // InnovAiT;Nov2009, Vol. 2 Issue 11, p673 

    The article presents an applied knowledge test on tumor markers.

  • Dysplasia in Barrett's Esophagus: Limitations of Current Management Strategies. Spechler, Stuart Jon // American Journal of Gastroenterology;Apr2005, Vol. 100 Issue 4, p927 

    Dysplasia is a very imperfect biomarker for malignancy in Barrett's esophagus. Invasive cancer has been found in 30–40% of esophagi resected because preoperative endoscopic examinations had shown high-grade dysplasia. Reports on the natural history of this disorder are sometimes...

  • QUALITY OF LIFE ASSESSMENT IN PATIENTS UNDERGOING ENDOSCOPIC MUCOSAL ABLATION FOR DYSPLASTIC BARRETT'S OESOPHAGUS. Ragunath, K.; Krasner, N.; Raman, V.S.; Haqqani, M.T.; Cheung, W.Y. // Gut;Apr2003 Supplement 1, Vol. 52, pA42 

    Background: A number of thermal and non-thermal modalities have been applied in an effort to eradicate dysplasia and reverse the Barrett's epithelium. Quality of life (QOL) assessment is an important outcome measure, since these interventions result in procedure related morbidity. Aim: To assess...

  • Plectin-1 is a biomarker of malignant pancreatic intraductal papillary mucinous neoplasms. Bausch, Dirk; Mino-Kenudson, Mari; Fernández-del Castillo, Carlos; Warshaw, Andrew L.; Kelly, Kimberly A.; Thayer, Sarah P.; Fernández-Del Castillo, Carlos // Journal of Gastrointestinal Surgery;Nov2009, Vol. 13 Issue 11, p1948 

    Introduction: Pancreatic intraductal papillary mucinous neoplasms (IPMN) are now identified with increasing frequency. The detection of carcinoma in IPMN is difficult and suffers from high false-positive and false-negative rates, often resulting in inappropriate treatment decisions....

  • P16INK4A CDC6 and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer. Murphy, N.; Ring, M.; Heffron, C. C. B. B.; King, B.; Killalea, A. G.; Hughes, C.; Martin, C. M.; McGuinness, E.; Sheils, O.; O'Leary, J. J. // Journal of Clinical Pathology;May2005, Vol. 58 Issue 5, p525 

    Aim: To analyse and compare expression patterns of three potential biomarkers-p16INK4A CDC6, and MCM5-and evaluate their use as predictive biomarkers in squamous and glandular cervical preinvasive neoplasia. Methods: lmmunocytochemical analysis of p16INK4A, MCM5, and CDC6 expression was...

  • Primary Sclerosing Cholangitis Detection of Cancer in Strictures. Schulick, Richard D. // Journal of Gastrointestinal Surgery;Mar2008, Vol. 12 Issue 3, p420 

    Primary sclerosing cholangitis (PSC) is a significant risk factor for developing cholangiocarcinoma. Tests currently used to screen patients with PSC include serum tumor markers, invasive biliary imaging and sampling techniques, and noninvasive biliary imaging. The most commonly used serum...

  • Intestinal epithelial dysplasia (tufting enteropathy). Goulet, Olivier; Salomon, Julie; Ruemmele, Frank; Patey-Mariaud de Serres, Natacha; Brousse, Nicole // Orphanet Journal of Rare Diseases;2007, Vol. 2, p20 

    Intestinal epithelial dysplasia (IED), also known as tufting enteropathy, is a congenital enteropathy presenting with early-onset severe intractable diarrhea causing sometimes irreversible intestinal failure. To date, no epidemiological data are available, however, the prevalence can be...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics